IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%
IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%
Read moreTue, 24th Jan 2012 16:32
IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%
Read moreIN BRIEF: Immupharma Repays Lind Global Convertible Security
Read moreIN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission
Read more(Sharecast News) - Specialist drug discovery and development company ImmuPharma on its special protocol assessment (SPA) submission to the US Food and Drug Administration (FDA) for the phase 3 trial of 'Lupuzor' in lupus patients.
Read moreImmupharma Raises GBP6.5 Million In Oversubscribed Placing
Read more(Sharecast News) - Drug discovery and development firm Immupharma has raised £6.5m, before fees, via an oversubscribed placing of 59.09m ordinary shares.
Read moreIN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor
Read more(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced what it called "an important regulatory milestone" on Monday, in preparation for the new optimised international phase 3 trial of 'Lupuzor' for the autoimmune disease systemic lupus erythematosus.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreImmupharma Gets Over USD6 Million Investment From US Healthcare Funds
Read moreUK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand
Read moreImmuPharma Annual Loss Narrows; Plans "Optimised" Lupuzor Trial
Read moreImmuPharma Raises GBP1.5 Million Through Share Issue To Fund Expansion
Read more(Sharecast News) - Drug discovery and development company ImmuPharma announced subscriptions to raise ?1.5m through the issue of 15 million new ordinary shares at a price of 10p each on Monday.
Read moreImmupharma Inks Subscription Agreement Amid Incanthera's NEX Float
Read more